Envestnet Asset Management Inc Athersys, Inc Transaction History

Envestnet Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	BUY	$0.18 - $0.86 $11,585 - $55,353	64,364 Added 274.68%	87,796 $23,000
Q1 2022 May 04, 2022	SELL	$0.6 - $1.06 $13,834 - $24,441	-23,058 Reduced 49.6%	23,432 $14,000
Q4 2021 Feb 04, 2022	BUY	$0.85 - $1.4 $9,678 - $15,941	11,387 Added 32.44%	46,490 $42,000
Q3 2021 Oct 07, 2021	BUY	$1.33 - $1.77 $2,904 - $3,865	2,184 Added 6.63%	35,103 $47,000
Q2 2021 Aug 04, 2021	BUY	$1.41 - $1.94 $5,840 - $8,035	4,142 Added 14.39%	32,919 $47,000
Q1 2021 May 04, 2021	BUY	$1.61 - $2.77 $5,356 - $9,215	3,327 Added 13.07%	28,777 $52,000
Q1 2020 Apr 23, 2020	BUY	$1.17 - $3.0 $292 - $750	250 Added 0.99%	25,450 $76,000
Q2 2019 Aug 02, 2019	BUY	$1.39 - $2.03 $35,028 - $51,155	25,200 New	25,200 $42,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.